A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder

NCT01624675 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder in Children and Adolescents

Interventions

DRUG: Risperidone
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.